These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 35232581)

  • 1. COVID-19 booster vaccination has not decreased access for low-income countries.
    Kalmar CL; Park BC; Patrinely JR; Drolet BC
    Public Health; 2022 Apr; 205():e18-e20. PubMed ID: 35232581
    [No Abstract]   [Full Text] [Related]  

  • 2. Real-world effectiveness of homologous and heterologous BNT162b2, CoronaVac, and AZD1222 booster vaccination against Delta and Omicron SARS-CoV-2 infection.
    Suah JL; Tng BH; Tok PSK; Husin M; Thevananthan T; Peariasamy KM; Sivasampu S
    Emerg Microbes Infect; 2022 Dec; 11(1):1343-1345. PubMed ID: 35499301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunity after COVID-19 and vaccination: follow-up study over 1 year among medical personnel.
    Glück V; Grobecker S; Köstler J; Tydykov L; Bertok M; Weidlich T; Gottwald C; Salzberger B; Wagner R; Zeman F; Koller M; Gessner A; Schmidt B; Glück T; Peterhoff D
    Infection; 2022 Apr; 50(2):439-446. PubMed ID: 34562263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of a COVID-19 Additional Primary or Booster Vaccine Dose in Preventing SARS-CoV-2 Infection Among Nursing Home Residents During Widespread Circulation of the Omicron Variant - United States, February 14-March 27, 2022.
    Prasad N; Derado G; Nanduri SA; Reses HE; Dubendris H; Wong E; Soe MM; Li Q; Dollard P; Bagchi S; Edwards J; Shang N; Budnitz D; Bell J; Verani JR; Benin A; Link-Gelles R; Jernigan J; Pilishvili T
    MMWR Morb Mortal Wkly Rep; 2022 May; 71(18):633-637. PubMed ID: 35511708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary COVID-19 vaccine cycle and booster doses efficacy: analysis of Italian nationwide vaccination campaign.
    Mattiuzzi C; Lippi G
    Eur J Public Health; 2022 Apr; 32(2):328-330. PubMed ID: 34978571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myopericarditis After COVID-19 Booster Dose Vaccination.
    Sharff KA; Dancoes DM; Longueil JL; Lewis PF; Johnson ES
    Am J Cardiol; 2022 Jun; 172():165-166. PubMed ID: 35351285
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases.
    Fragoulis GE; Karamanakos A; Arida A; Bournia VK; Evangelatos G; Fanouriakis A; Fragiadaki K; Kravvariti E; Laskari K; Panopoulos S; Papazoglou N; Pappa M; Tektonidou MG; Sfikakis PP
    RMD Open; 2022 Mar; 8(1):. PubMed ID: 35246472
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.
    Jara A; Undurraga EA; Zubizarreta JR; González C; Pizarro A; Acevedo J; Leo K; Paredes F; Bralic T; Vergara V; Mosso M; Leon F; Parot I; Leighton P; Suárez P; Rios JC; García-Escorza H; Araos R
    Lancet Glob Health; 2022 Jun; 10(6):e798-e806. PubMed ID: 35472300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 vaccination is highly effective to prevent SARS-CoV-2 circulation.
    Mattiuzzi C; Lippi G
    J Infect Public Health; 2022 Apr; 15(4):395-396. PubMed ID: 35299063
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of Gestational Age at Coronavirus Disease 2019 (COVID-19) Vaccination, History of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, and a Vaccine Booster Dose With Maternal and Umbilical Cord Antibody Levels at Delivery.
    Yang YJ; Murphy EA; Singh S; Sukhu AC; Wolfe I; Adurty S; Eng D; Yee J; Mohammed I; Zhao Z; Riley LE; Prabhu M
    Obstet Gynecol; 2022 Mar; 139(3):373-380. PubMed ID: 34963127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjudicating the logistics of COVID-19 vaccine boosters from a global perspective.
    Priyanka ; Choudhary OP; Singh I
    Hum Vaccin Immunother; 2022 Dec; 18(1):2020572. PubMed ID: 35026127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness analysis of BNT162b2 COVID-19 booster vaccination in the United States.
    Li R; Liu H; Fairley CK; Zou Z; Xie L; Li X; Shen M; Li Y; Zhang L
    Int J Infect Dis; 2022 Jun; 119():87-94. PubMed ID: 35338008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of a Third Dose of BNT162b2 Vaccine With Incidence of SARS-CoV-2 Infection Among Health Care Workers in Israel.
    Spitzer A; Angel Y; Marudi O; Zeltser D; Saiag E; Goldshmidt H; Goldiner I; Stark M; Halutz O; Gamzu R; Slobodkin M; Amrami N; Feigin E; Elbaz M; Furman M; Bronstein Y; Chikly A; Eshkol A; Furer V; Mayer T; Meijer S; Melloul A; Mizrahi M; Yakubovsky M; Rosenberg D; Safir A; Spitzer L; Taleb E; Elkayam O; Silberman A; Eviatar T; Elalouf O; Levinson T; Pozyuchenko K; Itzhaki-Alfia A; Sprecher E; Ben-Ami R; Henig O
    JAMA; 2022 Jan; 327(4):341-349. PubMed ID: 35006256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of third SARS-CoV-2 vaccine (booster dose) during pregnancy.
    Dick A; Rosenbloom JI; Karavani G; Gutman-Ido E; Lessans N; Chill HH
    Am J Obstet Gynecol MFM; 2022 Jul; 4(4):100637. PubMed ID: 35398583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies and safety considerations of booster vaccination in COVID-19.
    Meng H; Mao J; Ye Q
    Bosn J Basic Med Sci; 2022 Jun; 22(3):366-373. PubMed ID: 35366790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID Arm After Moderna Booster in Healthcare Worker: A Case Report.
    Saifuddin A; Koesnoe S; Kurniati N; Sirait S; Arisanty R; Yunihastuti E
    Acta Med Indones; 2021 Jul; 53(3):326-330. PubMed ID: 34611073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A disparity in the number of studies related to COVID-19 and SARS-CoV-2 between low- and middle-income countries and high-income countries.
    Usuzaki T; Chiba S; Shimoyama M; Ishikuro M; Obara T
    Int Health; 2021 Jul; 13(4):379-381. PubMed ID: 33130855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreasing neutralization antibody levels following vaccination against SARS-CoV-2 in the elderly: an observational study in Southern Moravia, Czech Republic.
    Mravčík V; Husa P; Kumpanová Valachovičová S; Vobořil J
    Epidemiol Mikrobiol Imunol; 2022; 71(1):9-20. PubMed ID: 35477266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCG vaccination at birth and COVID-19: a case-control study among U.S. military Veterans.
    Bates MN; Herron TJ; Lwi SJ; Baldo JV
    Hum Vaccin Immunother; 2022 Dec; 18(1):1981084. PubMed ID: 34643480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study.
    Menni C; May A; Polidori L; Louca P; Wolf J; Capdevila J; Hu C; Ourselin S; Steves CJ; Valdes AM; Spector TD
    Lancet Infect Dis; 2022 Jul; 22(7):1002-1010. PubMed ID: 35405090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.